25 - Mesenchymal Stem/Stromal Cells: MESENCURE: A PROFESSIONALIZED CELL THERAPY FOR ARDS REDUCED THE MORTALITY OF SEVERE COVID-19 PATIENTS BY 68% ACCORDING TO A RECENTLY CONCLUDED MULTI-CENTER, CONTROLLED PHASE II STUDY
| Autor: | Bronshtein, T., David, D. Ben, Novak, A., Kivity, V., Hayek, T., Rozen, N., Meretzki, S., Hamoud, S. |
|---|---|
| Zdroj: | In Cytotherapy May 2022 24(5) Supplement:S31-S32 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect